Artist Information Sample Clauses

Artist Information. Name: Name for use on label and public relations materials, if differs from above: Date of Birth: Place of Birth: Address: E-mail: Website (if any): Phone (business): Phone (home): Fax: One paragraph biography of Artist:
AutoNDA by SimpleDocs
Artist Information. NAME: ARTIST #: NOTE: IF YOU ARE NEW, YOUR NUMBER WILL BE ASSIGNED BY RETAIL MANAGER OR BOOKKEEPER SUMMER ADDRESS: WINTER ADDRESS: PHONE:_(home) (cell) EMAIL: ADDITIONAL INFORMATION: ● ARE YOU WILLING TO OFFER CLASSES or DEMONSTRATIONS IN YOUR MEDIUM? YES __ NO ● PLEASE GIVE AN EXAMPLE OF A TYPE OF CLASS/DEMO: ● IF YOU ARE AN AUTHOR/ILLUSTRATOR, WOULD YOU BE WILLING TO HAVE A BOOK SIGNING/TALK? YES NO ● WOULD YOU BE WILLING TO BE FEATURED IN A SPECIAL EXHIBITION AND/OR HAVE A TRUNK SHOW OF YOUR WORK? YES NO ● DO YOU GIVE XXXXX XXXX THE RIGHT TO PUBLISH PHOTOS OF YOUR WORK ON SOCIAL MEDIA, OUR WEBSITE AND IN EMAILS FOR PROMOTIONAL PURPOSES? YES NO
Artist Information. Artist Name: Birth Date: Tax ID, if Social Leave Blank: Artist Address: City/ State/ Zip: Phone Number: E-mail: Website: Social Media:
Artist Information. List of Works Submitted Fill out completely and print clearly. Name Email __ __ __ __ __ __ __ __ __ __ __ ___ Address __ __ __ __ __ __ __ __ City, State, Zip __ __ ___________________ __ __ __ __ ___ Student ID # OR Official ID # (driver license, passport, etc.): Occupation: Phone __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ __ _ Social Security #: will be requested if a purchase award or a patron offer to purchase is made. If work is not framed, may it be hung with magnets? yes no* *if no, work should be submitted framed or we may not be able to exhibit it! Title Medium Size Insurance / Sale Price** For Sale Yes/No ** You must list either a sale price if the work is available for sale or an insurance value if the work is not for sale. Do not leave this line blank! If a work is for sale, do not forget to factor in the 20% sales commission into your pricing.
Artist Information. It is the responsibility of each artist to promptly notify by mail or email regarding any changes in his or her personal contact information: mail and email addresses, telephone and fax numbers. If any such information changes, please notify immediately following the change. The artist is expected to provide with résumés updated annually and artistic statements appropriate to the art currently represented by the gallery. New artistic reviews, lists of exhibitions or accomplishments, and other such information should be kept accurate and current at all times, for the purpose of representing the artist professionally, during the time of the sale and for the appraisal packets given to each collector. Any information about your art that can help sell your work should be sent to . Even if you have shown at the gallery for a while, new works contain new narratives. Help us to sell your work by sending us information about the techniques used, myths conjured, and experiences captured in each new work. A short paragraph is sufficient. Send all new information as a Word Doc or PDF and email attachment, so we can transfer it electronically to our letterhead, website, etc.
Artist Information. The Exhibitor agrees to furnish the EAC an inventory list of the objects to be exhibited. The inventory should include the following: Title, Date, Medium, Dimensions (h” x w” x d”), and the retail price or insurance value if not for sale. The Exhibitor determines the retail value or insurance price. The inventory should accompany the work when delivered or shipped.
Artist Information. Fill out completely and print clearly. Name Email __ __ __ __ __ __ __ __ __ __ __ ___ Address __ __ __ __ __ __ __ __ City, State, Zip __ __ ___________________ __ __ __ __ ___ Student ID # Major Class Standing (circle one): Freshman Sophomore Junior Senior
AutoNDA by SimpleDocs
Artist Information. The Company expressly acknowledges and agrees that Artist’s privacy is highly valued. Accordingly, the Company hereby agrees that all efforts will be made by the Company Group, their agents, employees, representatives, contractors and attorneys to maintain Artist’s privacy and confidentiality with respect to confidential information received by the Company Group concerning Artist including, confidential information regarding Artist’s entertainment or business activities, financial affairs or personal life, except for information or material publicly and intentionally disclosed by Artist for general dissemination to the public (or approved in advance by Lender in writing to be disclosed).
Artist Information 

Related to Artist Information

  • Client Information (2) Protected Health Information in any form including without limitation, Electronic Protected Health Information or Unsecured Protected Health Information (herein “PHI”);

  • Current Information (a) During the period from the date of this Agreement to the Closing, each Party hereto shall promptly notify each other Party of any (i) significant change in its ordinary course of business, (ii) proceeding (or communications indicating that the same may be contemplated), or the institution or threat or settlement of proceedings, in each case involving the Parties the outcome of which, if adversely determined, could reasonably be expected to have a material adverse effect on the Party, taken as a whole or (iii) event which such Party reasonably believes could be expected to have a material adverse effect on the ability of any party hereto to consummate the Share Exchange.

  • Product Information EPIZYME recognizes that by reason of, inter alia, EISAI’s status as an exclusive licensee in the EISAI Territory under this Agreement, EISAI has an interest in EPIZYME’s retention in confidence of certain information of EPIZYME. Accordingly, until the end of all Royalty Term(s) in the EISAI Territory, EPIZYME shall keep confidential, and not publish or otherwise disclose, and not use for any purpose other than to fulfill EPIZYME’s obligations, or exercise EPIZYME’s rights, hereunder any EPIZYME Know-How Controlled by EPIZYME or EPIZYME Collaboration Know-How, in each case that are primarily applicable to EZH2 or EZH2 Compounds (the “Product Information”), except to the extent (a) the Product Information is in the public domain through no fault of EPIZYME, (b) such disclosure or use is expressly permitted under Section 9.3, or (c) such disclosure or use is otherwise expressly permitted by the terms and conditions of this Agreement. For purposes of Section 9.3, each Party shall be deemed to be both the Disclosing Party and the Receiving Party with respect to Product Information. For clarification, the disclosure by EPIZYME to EISAI of Product Information shall not cause such Product Information to cease to be subject to the provisions of this Section 9.2 with respect to the use and disclosure of such Confidential Information by EPIZYME. In the event this Agreement is terminated pursuant to Article 12, this Section 9.2 shall have no continuing force or effect, but the Product Information, to the extent disclosed by EPIZYME to EISAI hereunder, shall continue to be Confidential Information of EPIZYME, subject to the terms of Sections 9.1 and 9.3 for purposes of the surviving provisions of this Agreement. Each Party shall be responsible for compliance by its Affiliates, and its and its Affiliates’ respective officers, directors, employees and agents, with the provisions of Section 9.1 and this Section 9.2.

  • Parent Information The information relating to Parent and its Subsidiaries to be contained in the Proxy Statement and the S-4, or in any other document filed with any other regulatory agency in connection herewith, will not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements therein, in light of the circumstances in which they are made, not misleading. The Proxy Statement (except for such portions thereof that relate to the Company or any of its Subsidiaries) will comply with the provisions of the Exchange Act and the rules and regulations thereunder. The S-4 will comply with the provisions of the Securities Act and the rules and regulations thereunder.

  • Contact Information 1. The contact information of the Programme Operator is as specified in this programme agreement.

  • PROCESS INFORMATION Describe planned use, and include brief description of manufacturing processes employed.

  • Payment Information 3.1 The Authority shall issue a purchase order to the Contractor prior to commencement of the Service.

  • KYC Information (i) Upon the reasonable request of any Lender made at least five (5) days prior to the Closing Date, the Borrowers shall have provided to such Lender, and such Lender shall be reasonably satisfied with, the documentation and other information so requested in connection with applicable “know your customer” and anti-money-laundering rules and regulations, including, without limitation, the PATRIOT Act, in each case at least five (5) days prior to the Closing Date.

  • Protection of Trade Secrets and Confidential Information (a) Definition of “

  • Confidential Information Protections 4.1 At all times during and after the Employee’s employment, the Employee will hold in confidence and will not disclose, use, lecture upon, or publish any of Company’s Confidential Information (defined below), except as may be required in connection with the Employee’s work for Company, or as expressly authorized by the Board. The Employee will obtain the written approval of the Board before publishing or submitting for publication any material (written, oral, or otherwise) that relates to the Employee’s work at Company and/or incorporates any Confidential Information. The Employee hereby assigns to Company any rights the Employee may have or acquire in any and all Confidential Information and recognize that all Confidential Information shall be the sole and exclusive property of Company and its assigns.

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!